Erik Schropp

Erik Schropp

Director/Board Member at POLYPEPTIDE GROUP AG

Net worth: 107 414 $ as of 30/03/2024

60 year
Health Technology
Finance
Commercial Services

Profile

Erik Schropp is currently the Chief Executive Officer at C&P Investors Ltd., Director at Haydn Holding AB, Non-Executive Director at PolyPeptide Group AG, Director at SEVER Life Sciences BV, Director at Draupnir Holding BV, Director at Svar Life Science AB, and Director at Ferring Foundation BV.
Previously, he worked as the Director-International Tax & Finance at Ferring Pharmaceuticals A, Director at Altacor Ltd., Director at PolyPeptide Laboratories Holding BV, Director at PolyPeptide Laboratories Holding (PPL) AB, and Director at FinVector Oy.
He also worked as the Manager-International Tax at Unisource NV and Tax Manager at Arthur Andersen Accountants.
Mr. Schropp graduated from Erasmus University Rotterdam in 1988.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/12/2022 3,193 ( 0.01% ) 107 414 $ 30/03/2024

Erik Schropp active positions

CompaniesPositionStart
POLYPEPTIDE GROUP AG Director/Board Member 31/12/2020
C&P Investors Ltd. Chief Executive Officer 31/12/2019
Director/Board Member 31/12/2007
SEVER Life Sciences BV Director/Board Member 31/12/2018
Director/Board Member 31/12/2007
Haydn Holding AB Director/Board Member 31/12/2011
Director/Board Member 31/12/2007
All active positions of Erik Schropp

Former positions of Erik Schropp

CompaniesPositionEnd
Director/Board Member 31/12/2020
Director/Board Member 31/12/2020
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Erik Schropp's experience

Training of Erik Schropp

Erasmus University Rotterdam Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Erik Schropp's experience

Connections

65

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
POLYPEPTIDE GROUP AG

Health Technology

Private companies13

Communications

Health Technology

Finance

Finance

Commercial Services

Haydn Holding AB

C&P Investors Ltd.

Health Technology

SEVER Life Sciences BV

Commercial Services

Commercial Services

Finance

Health Technology

See company connections